Você está na página 1de 5

UY, CHELSEIY S

BS PHARMACY 4A

Self-Directed Activity - Generics Act of 1988, A.O. 62, A.O. 63, A.O. 90

Please refer to pages 169-179 of the PDF “PNDF – A.O. 63 s. 1990” for answers to the
following questions:

1. What is a dangerous drug?

Dangerous drugs refer to either prohibited drugs or regulated drugs which require a
special prescription form, the use of which is monitored by the by the Dangerous Drug
Board.

2. What are prohibited drugs and give examples of such drugs?

Prohibited drugs include "opium and its active components and derivatives such as
heroin and morphine; coca leaf and its derivatives, principally cocaine, alpha and beta
Eucaine, hallucinogenic drugs, such as mescaline lysergic acid diethylamide (LSD) and
other substances producing similar effects; Indian hemp and its derivatives; all preparations
made from any of the foregoing; and other drugs, whether natural or synthetic, with the
physiological effects of a narcotic drug.

3. What are regulated drugs and give examples of such drugs?

Regulated drugs includes sleep‐inducing sedatives, such as secobarbital, phenobarbital,


barbital, amobarbital and other drugs which contain a salt derivative of a salt of an isomer of
amphetamine, such as benzedrine or dexedrine, or any drug which produces a
pharmacologic action similar to amphetamine; and hypnotic drugs such as methaqualone, or
any other compound producing similar pharmacologic effects.
4. Provide guidelines on prescribing in reference to A.O. 62 s. 1990.

In order to have an integrated implementation of all relevant guidelines on


prescribing, these guidelines based on prior laws are restated here under:

1. Only validly‐registered medical, dental and veterinary practitioners, whether in


private practice or employed in a private institution/corporation or in the government,
are authorized to prescribe drugs. Prescribing by unauthorized persons constitutes
illegal practice of medicine, dentistry or veterinary medicine punishable under R.A.
2382 or the Medical Act of 1959, R.A. 4419 or the Dental Act, R.A. 382 or the
Veterinary Act.
2. In accordance with R.A. 5921, or the Pharmacy Act as amended, all prescriptions
must contain the following information: name of prescriber, office address,
professional registration number, professional tax receipt number, patient's/client's
name, age and sex, and date of prescription.
3. For drugs in List A (Annex I) containing the list of Prohibited Drugs and Regulated
Drugs as approved by the Dangerous Drugs Board (DDB), the following are required:
a. The prescriber must have an S‐2 license.
b. The special DDB prescription form must be used.
c. A recording system following pertinent DDB regulations must be observed.

5. Differentiate an erroneous, violative and impossible prescription as indicated by A.O.


62 s. 1990 and actions that should be done when receiving such prescriptions.

 Violative prescriptions


Where generic name is not written.

Where the generic name is not legible and a brand name which is legible is
written.

Where the brand name is indicated and instructions added (such as the
phrase "no substitution") which tend to obstruct, hinder or prevent proper generic
dispensing.

Actions that should be done when receiving Violative prescriptions:

Violative prescriptions shall not be filled. They shall be kept and


reported by the pharmacist of the drug outlet or any other interested party to the
nearest DOH Office for appropriate action. The pharmacist shall advise the
prescriber of the problem and/or instruct the customer to get the proper
prescription.

 Erroneous prescriptions


Where the brand name precedes the generic name

Where the generic name is the one in parenthesis

Where the brand name is not in parenthesis

Where more than one drug product is prescribed on one prescription form.

Actions that should be done when receiving Erroneous prescriptions:

Erroneous prescriptions shall be filled. Such prescription shall also be


kept and reported by the pharmacist of the drug outlet or any other interested
party to the nearest DOH Office for appropriate action.

 Impossible prescriptions


When only the generic name is written but it is not legible

When the generic name does not correspond to the brand name

When both the generic name and the brand name are not legible

When the drug product prescribed is not registered with the BFAD
Actions that should be done when receiving Impossible prescriptions:

Impossible prescriptions shall not be filled. They shall be kept and


reported by the pharmacist of the drug outlet or any other interested party to
the nearest DOH Office for appropriate action. The pharmacist shall advise
the prescriber of the problem and/or instruct the customer to get the proper
prescription.

6. What are the different violations on the part of dispensers and outlets in response to
A.O. 63 s. 1990?

The following acts or omissions are considered violations:



Imposing a particular brand or product on the buyer.

Inaccurate dispensing i.e. dispensing a drug product which does not meet the
prescription as to any or all of the following: active ingredient, dosage form
and strength.

Failure to post or make accessible the required up‐to‐date information on drug
products.

Failure to adequately inform the buyer on available products that meet the
prescription.

Failure to indicate the generic name/official name designated by BFAD and
other required information on the drug outlet's label of the dispensed drug.

Failure to record and keep prescriptions filled.

Failure to report to the nearest DOH office cases of violative, erroneous,
and/or impossible prescriptions within three months after receipt of such
prescriptions.
7. What does A.O. 90 s. 1990 talk about?

A.O 90 s. 1990 talks about the request of prescribing doctors to allow them to
write the name of more than one drug product on the same page of a prescription form
for a particular patient and it also no longer regards a prescription form with more than
one drug product as erroneous.

8. How are filled prescriptions processed in accordance to A.O. 63 s. 2000?

Whenever an ordinary prescription (Rx) in duplicate copies is filled by a


drugstore, it shall be incumbent upon the pharmacist to use the word “FILLED” to be
stamped in bold prints diagonally across the original copy of the said prescription in
case the full quantity of the drug therein stated is sold returning the duplicate copy to the
buyer. The words “USED FOR _______ shall be stamped on the face of the
prescription, in case the quantity of the drug herein stated is not fully sold, and to return
both copies of the partially filled prescription to the buyer after recording the partial
filling in the prescription book pursuant to Sec. 3.3 of A.O 63 s. 1989.

Você também pode gostar